Another win for antibody-drug conjugates in breast cancer
This is index.php
Another win for antibody-drug conjugates in breast cancer
Another win for antibody-drug conjugates in breast cancer The results of the pivotal efficacy trial of sacituzumab govitecan, an innovative antibody-drug conjugate developed by Gilead Sciences, have just been published in The Lancet, showing improved survival of HR-positive, EGFR2-negative breast cancer patients receiving the new drug. In this trial, 543 subjects were randomized to treatment […]
Updated Novavax’s COVID vaccine effectively neutralizes…
Updated Novavax’s COVID vaccine effectively neutralizes newly emerging SARS-CoV-2 variants The updated Novavax’s COVID-19 vaccine has been reported to effectively neutralize EG.5.1 and XBB.1.16.6 subvariants, which were designated as variants of interest (VOIs) by WHO and are currently circulating all over the globe (majority of COVID cases in the EU and US are now EG.5.1 […]
Market welcomes the arrival of new RSV vaccines
Market welcomes the arrival of new RSV vaccines Pfizer has announced positive decision of FDA on the approval of its protein RSV vaccine for older adults. The product is expected to be launched before the arrival of the next RSV season this winter (third quarter). After the COVID-19 pandemic and long-term isolation from various pathogens, […]